Frida Leonetti

Pubblicazioni

Titolo Pubblicato in Anno
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk THE LANCET REGIONAL HEALTH. EUROPE 2024
Sex-Differences in Response to Treatment with Liraglutide 3.0 mg JOURNAL OF CLINICAL MEDICINE 2024
Remission of type 2 diabetes: position statement of the Italian society of diabetes (SID) ACTA DIABETOLOGICA 2024
Sex differences in anti-obesity drugs: is it time to be more proactive in engaging men? JOURNAL OF CLINICAL RESEARCH AND MEDICINE 2024
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease HEPATOLOGY INTERNATIONAL 2023
Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2023
Short-term effectiveness of dapagliflozin versus {DPP}-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Validation in type 2 diabetes of a metabolomic signature of all-cause mortality DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus CARDIOVASCULAR DIABETOLOGY 2023
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus DIABETES & METABOLISM 2023
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus DIABETES & METABOLISM 2023
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Advice of General Practitioner, of Surgeon, of Endocrinologist, and Self‑determination: the Italian Road to Bariatric Surgery OBESITY SURGERY 2022
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes DIABETES & METABOLISM 2022
Non-invasive tests for fibrosis detection: still in search for the best way HEPATOBILIARY SURGERY AND NUTRITION 2022
Correction: Advice of General Practitioner, of Surgeon, of Endocrinologist, and Self-Determination: the Italian Road to Bariatric Surgery (Obesity Surgery, (2022), 32, 6, (1996-2002), 10.1007/s11695-022-06042-8) OBESITY SURGERY 2022
Differential involvement of myelinated and unmyelinated nerve fibers in painful diabetic polyneuropathy MUSCLE & NERVE 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma